These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 311881)
21. Immune defects in patients with head and neck cancer. Wustrow TP; Issing WJ Anticancer Res; 1993; 13(6B):2507-19. PubMed ID: 8135491 [TBL] [Abstract][Full Text] [Related]
22. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082 [TBL] [Abstract][Full Text] [Related]
23. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620 [TBL] [Abstract][Full Text] [Related]
24. Peripheral blood lymphocytes and their subpopulations in lung carcinoma. Zółtowska A; Skokowski J; Mlekodaj S; Boj E Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027 [TBL] [Abstract][Full Text] [Related]
25. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)]. Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392 [TBL] [Abstract][Full Text] [Related]
26. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease. Levo Y; Rotter V; Ramot B Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352 [TBL] [Abstract][Full Text] [Related]
27. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma. Wolf GT; Carey TE J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697 [TBL] [Abstract][Full Text] [Related]
28. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322 [TBL] [Abstract][Full Text] [Related]
29. Immunologic evaluation and prognosis in patients with head and neck cancer. Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057 [TBL] [Abstract][Full Text] [Related]
30. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer. Papac R; Minor DR; Rudnick S; Solomon LR; Capizzi RL Cancer Res; 1978 Oct; 38(10):3150-3. PubMed ID: 356962 [TBL] [Abstract][Full Text] [Related]
31. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation]. Karwowska W; Kunicka A Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690 [TBL] [Abstract][Full Text] [Related]
32. Immunology of head and neck cancers. Newbill ET; Johns ME Crit Rev Clin Lab Sci; 1983; 19(1):1-25. PubMed ID: 6201320 [TBL] [Abstract][Full Text] [Related]
33. Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Karcher J; Dyckhoff G; Beckhove P; Reisser C; Brysch M; Ziouta Y; Helmke BH; Weidauer H; Schirrmacher V; Herold-Mende C Cancer Res; 2004 Nov; 64(21):8057-61. PubMed ID: 15520216 [TBL] [Abstract][Full Text] [Related]
34. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014 [TBL] [Abstract][Full Text] [Related]
35. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions. Berlinger NT; Good RA Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999 [No Abstract] [Full Text] [Related]
36. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research]. Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422 [TBL] [Abstract][Full Text] [Related]
37. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole. Basch CM; Spitler LE; Engleman EG; Engleman EP J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477 [TBL] [Abstract][Full Text] [Related]
38. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of poor CD3 response in head and neck cancer. Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904 [TBL] [Abstract][Full Text] [Related]
40. Cell-mediated immune response during specific hyposensitization in atopic asthma patients. Moniuszko T; Chyrek-Borowska S; Moniuszko C Arch Immunol Ther Exp (Warsz); 1984; 32(4):375-80. PubMed ID: 6335958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]